|Bid||84.24 x 900|
|Ask||285.53 x 1200|
|Day's Range||262.45 - 268.80|
|52 Week Range||218.28 - 324.81|
|Beta (5Y Monthly)||0.70|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 21, 2022 - Feb 25, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||317.13|
Subscribe to Yahoo Finance Plus to view Fair Value for PODDLearn more
ACTON, Mass., November 24, 2021--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the virtual 45th Nasdaq Investor Conference on Friday, December 3, 2021 at 11:30 a.m. (Eastern Time).
Insulet offered a mixed third-quarter report, but PODD stock popped to a record high on Friday after the company boosted its 2021 outlook.
Insulet (PODD) reports better-than-expected revenues for third-quarter 2021 on strong performance of Omnipod, both in U.S. and international markets.